Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data ; volume:20 ; number:1 ; day:16 ; month:12 ; year:2019 ; pages:1-17 ; date:12.2019
BMC bioinformatics ; 20, Heft 1 (16.12.2019), 1-17, 12.2019
- Creator
-
De Velasco Oriol, Javier
Vallejo, Edgar E.
Estrada, Karol
Taméz Peña, José Gerardo
Disease Neuroimaging Initiative, The Alzheimer’s
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-019-3158-x
- URN
-
urn:nbn:de:101:1-2020040703032590352494
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- De Velasco Oriol, Javier
- Vallejo, Edgar E.
- Estrada, Karol
- Taméz Peña, José Gerardo
- Disease Neuroimaging Initiative, The Alzheimer’s
- SpringerLink (Online service)
Other Objects (12)
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease